# Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition

> **NCT04549480** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 66 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Bosutinib capsule
- **DRUG:** Bosutinib tablet

## Key facts

- **NCT ID:** NCT04549480
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-16
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04549480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04549480, "Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04549480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*